Nisha E. Mathew

Nisha E. Mathew

Auto-generated profile, based on publicly available information

Nisha E. Mathew

Neuroscience Research Australia, Randwick, NSW2031, Australia; School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, NSW 2052, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Cell
Verified
Journal Article
Closed access
CYChloe X. Yap
Chloe X. Yap
AHAnjali K. Henders
Anjali K. Henders
GAGail A. Alvares
Gail A. Alvares
DWDavid L.A. Wood
David L.A. Wood
LKLutz Krause
Lutz Krause
JGJacob Gratten
Jacob Gratten

26 August 2022 in Autism Research
Verified
Journal Article
Open access
NMNisha E. Mathew
Nisha E. Mathew
KMKylie‐Ann Mallitt
Kylie‐Ann Mallitt
AMAnne Masi
Anne Masi
TKTamarah Katz
Tamarah Katz
AWAdam K Walker
Adam K Walker
KOKeith Ooi
Keith Ooi
Diets of children and adolescents on the autism spectrum often differ when compared to their non‐autistic peers. Most dietary studies have been limited by small sample sizes and rarely assess the heterogeneity of autism. Addressing this gap, this study compared the anthropometrics, dietary composition, dietary quality, and food variety of 154 Australian children and adolescents on the spectrum and 213 non‐autistic children (71 siblings and 142 unrelated controls). Beyond the case‐control approach, within‐group comparisons assessed the influence of autism clinical presentations and sensory processing styles on body mass index (BMI) and measures of dietary intake among those on the spectrum. In this word first study of diet that included between‐group comparisons with non‐autistic peers (siblings and an unrelated comparison group) and within‐autism group comparisons, we found that children on the spectrum consumed limited variety and lower quality of food and non‐autistic siblings also ate comparably higher levels of energy‐dense, nutrient poor food, and less diary. This may be due to autistic traits influencing family's diets or shared sensory sensitivities driving dietary intake. Within the autism group, higher autistic traits were associated with lower BMIs and a specific dietary pattern higher in simple carbohydrates and lower in unprocessed protein. Contrastingly, greater sensitivity to sensory stimuli was associated with a healthier diet. Increased age was linked to more varied diets but also diets higher in saturated fats and energy‐dense, nutrient poor foods. Overall, this research highlights that potential mediators of dietary intake, such as familial influences, autistic traits, sensory processing styles, age and sex, need to be considered when assessing diet in the autistic population.Lay Summary: In this study of dietary differences linked to autism, children, and teenagers on the spectrum ate fewer different foods and were less likely to eat recommended amounts of fruits and vegetables when compared to non‐autistic siblings and unrelated children and teenagers. There were also family differences, in that those on the spectrum and their siblings ate more unhealthy foods and less dairy. Among those on the spectrum, dietary differences were linked to age, sex, autistic traits and sensory processing styles.

10 February 2021 in Molecular Autism
Verified
Journal Article
Open access
PDF file
CYChloe X. Yap
Chloe X. Yap
GAGail A. Alvares
Gail A. Alvares
AHAnjali K. Henders
Anjali K. Henders
TLTian Lin
Tian Lin
LWLeanne Wallace
Leanne Wallace
JGJacob Gratten
Jacob Gratten
Background: Autism spectrum disorder (ASD) is a complex neurodevelopmental condition whose biological basis is yet to be elucidated. The Australian Autism Biobank (AAB) is an initiative of the Cooperative Research Centre for Living with Autism (Autism CRC) to establish an Australian resource of biospecimens, phenotypes and genomic data for research on autism. Methods: Genome-wide single-nucleotide polymorphism genotypes were available for 2,477 individuals (after quality control) from 546 families (436 complete), including 886 participants aged 2 to 17 years with diagnosed (n = 871) or suspected (n = 15) ASD, 218 siblings without ASD, 1,256 parents, and 117 unrelated children without an ASD diagnosis. The genetic data were used to confirm familial relationships and assign ancestry, which was majority European (n = 1,964 European individuals). We generated polygenic scores (PGS) for ASD, IQ, chronotype and height in the subset of Europeans, and in 3,490 unrelated ancestry-matched participants from the UK Biobank. We tested for group differences for each PGS, and performed prediction analyses for related phenotypes in the AAB. We called copy-number variants (CNVs) in all participants, and intersected these with high-confidence ASD- and intellectual disability (ID)-associated CNVs and genes from the public domain. Results: The ASD (p = 6.1e−13), sibling (p = 4.9e−3) and unrelated (p = 3.0e−3) groups had significantly higher ASD PGS than UK Biobank controls, whereas this was not the case for height—a control trait. The IQ PGS was a significant predictor of measured IQ in undiagnosed children (r = 0.24, p = 2.1e−3) and parents (r = 0.17, p = 8.0e−7; 4.0% of variance), but not the ASD group. Chronotype PGS predicted sleep disturbances within the ASD group (r = 0.13, p = 1.9e−3; 1.3% of variance). In the CNV analysis, we identified 13 individuals with CNVs overlapping ASD/ID-associated CNVs, and 12 with CNVs overlapping ASD/ID/developmental delay-associated genes identified on the basis of de novo variants. Limitations: This dataset is modest in size, and the publicly-available genome-wide-association-study (GWAS) summary statistics used to calculate PGS for ASD and other traits are relatively underpowered. Conclusions: We report on common genetic variation and rare CNVs within the AAB. Prediction analyses using currently available GWAS summary statistics are largely consistent with expected relationships based on published studies. As the size of publicly-available GWAS summary statistics grows, the phenotypic depth of the AAB dataset will provide many opportunities for analyses of autism profiles and co-occurring conditions, including when integrated with other omics datasets generated from AAB biospecimens (blood, urine, stool, hair).

20 April 2023 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
RVRachel Visontay
Rachel Visontay
LMLouise Mewton
Louise Mewton
MSMatthew Sunderland
Matthew Sunderland
SBSteven Bell
Steven Bell
ABAnnie Britton
Annie Britton
TSTim Slade
Tim Slade

1 September 2019 in IBRO Reports
Verified
Journal Article
Open access
Valsamma EapenValsamma Eapen
Valsamma Eapen
NMNisha Mathew
Nisha Mathew
AMAmanda Mazzoni
Amanda Mazzoni